CHINA BIOLOGIC PRODS HLDGS I's ticker is and the CUSIP is G21515954. A total of 2 filers reported holding CHINA BIOLOGIC PRODS HLDGS I in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $0 | -100.0% | 17 | +112.5% | 0.00% | – |
| Q4 2020 | $94,000 | -94.8% | 8 | -95.1% | 0.00% | -100.0% |
| Q3 2020 | $1,800,000 | +508.1% | 162 | +458.6% | 0.00% | – |
| Q2 2020 | $296,000 | -57.1% | 29 | -54.7% | 0.00% | -100.0% |
| Q1 2020 | $690,000 | +23.7% | 64 | +33.3% | 0.00% | 0.0% |
| Q4 2019 | $558,000 | -84.6% | 48 | -84.8% | 0.00% | -90.0% |
| Q3 2019 | $3,617,000 | +1126.1% | 316 | +919.4% | 0.01% | +900.0% |
| Q2 2019 | $295,000 | +3177.8% | 31 | +3000.0% | 0.00% | – |
| Q1 2019 | $9,000 | -97.7% | 1 | -98.0% | 0.00% | -100.0% |
| Q4 2018 | $387,000 | -66.9% | 51 | -65.1% | 0.00% | -75.0% |
| Q3 2018 | $1,168,000 | +22.6% | 146 | +52.1% | 0.00% | 0.0% |
| Q2 2018 | $953,000 | +6253.3% | 96 | +41.2% | 0.00% | +300.0% |
| Q3 2017 | $15,000 | – | 68 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| SIMPLEX TRADING, LLC | 8 | $94,000 | 0.00% |